Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Mycobacterium Avium Complex (MAC) Lung Disease: Effect of Baseline Amikacin and Clarithromycin Susceptibility on Culture Conversion

被引：0
|
作者：
Winthrop, K. L. [1 ]
Flume, P. A. [2 ,3 ]
Thomson, R. [4 ]
Brown-Elliott, B. A. [5 ]
Wallace, R. J., Jr. [5 ]
Griffith, D. E. [6 ]
Pennings, L. J. [7 ]
Coulter, C. [8 ]
Syrmis, M. [8 ]
Pandey, S. [8 ]
Yuen, D. [9 ]
Mange, K. [9 ]
van Ingen, J. [7 ]
机构：
[1] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA
[2] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA
[3] Med Univ South Carolina, Dept Pediat, Charleston, SC 29425 USA
[4] Univ Queensland, Gallipoli Med Res Inst, Brisbane, Qld, Australia
[5] Univ Texas Hlth Sci Ctr Tyler, Mycobacteria Nocardia Lab, Tyler, TX USA
[6] Univ Texas Hlth Sci Ctr Tyler, Tyler, TX USA
[7] Radboud Univ Nijmegen Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands
[8] Pathol Queensland, Queensland Mycobacterium Reference Lab, Brisbane, Qld, Australia
[9] Insmed Inc, Bridgewater, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4494
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use (vol 41, pg 405, 2021)
    Hoy, Sheridan M.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (06) : 591 - 591
  • [32] A Retrospective Analysis to Assess the Discontinuation of Amikacin Liposome Inhalation Suspension Therapy Among Patients Treated for Refractory Mycobacterium Avium Complex Lung Disease
    Puc, M.
    Koerner, P.
    Russian, A.
    Faris, R.
    Vanscoy, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [33] Amikacin Liposome Inhalation Solution (ALIS) for Treatment Refractory Pulmonary Mycobacterium Avium Complex; A Report of the First 50 Patients Who Have Received ALIS and Their Tolerance in a Tertiary Referral Center
    Kasperbauer, S. H.
    Levin, A. R.
    Huitt, G. A.
    Daley, C. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [34] Diagnosis and Management of Drug-Induced Interstitial Lung Disease Associated with Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium Avium Complex Pulmonary Disease: A Case Report
    Hashimoto, Kazuki
    Nii, Takuro
    Sumitani, Hitoshi
    Yokoyama, Masashi
    Miyamoto, Satoshi
    Mihashi, Yasuhiro
    Nagata, Yuka
    Matsuki, Takanori
    Tsujino, Kazuyuki
    Miki, Keisuke
    Kida, Hiroshi
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 6629 - 6634
  • [35] The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults
    Khan, Omer
    Chaudary, Nauman
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 2287 - 2294
  • [36] Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease A 12-Month Open-Label Extension Clinical Trial
    Winthrop, Kevin L.
    Flume, Patrick A.
    Thomson, Rachel
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Morimoto, Kozo
    Ruoss, Stephen J.
    Codecasa, Luigi R.
    Yim, Jae-Joon
    Marras, Theodore K.
    van Ingen, Jakko
    Wallace, Richard J., Jr.
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Griffith, David E.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1147 - 1157
  • [37] A Retrospective Analysis to Assess the Effect of Targeted Clinical Interventions on the Discontinuation Rate of Amikacin Liposome Inhalation Suspension Therapy Among Patients Treated for Refractory Mycobacterium Avium Complex Lung Disease
    Hebble, S.
    Puc, M.
    Koerner, P.
    Barry, B.
    Faris, R.
    Vanscoy, G. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [38] Clinical study of 20 cases of refractory Mycobacterium avium complex pulmonary disease treated with amikacin liposomal inhalation suspension
    Kaneko, Taichi
    Hagiwara, Eri
    Okuda, Ryo
    Ogura, Takashi
    RESPIROLOGY, 2024, 29 : 48 - 49
  • [39] Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease
    Siegel, Sarah A. R.
    Griffith, David E.
    Philley, Julie V.
    Brown-Elliott, Barbara A.
    Brunton, Amanda E.
    Sullivan, Peter E.
    Fuss, Cristina
    Strnad, Luke
    Wallace Jr, Richard J.
    Winthrop, Kevin L.
    CHEST, 2023, 164 (04) : 846 - 859
  • [40] A Case of Single-lung Transplant in a Patient with Mycobacterium avium Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension
    Ozeki, Taichi
    Higo, Hisao
    Omori, Hiroki
    Mori, Shunta
    Tanaka, Shin
    Makimoto, Go
    Ninomiya, Kiichiro
    Taniguchi, Akihiko
    Fujii, Masanori
    Miyoshi, Kentaro
    Rai, Kammei
    Ichihara, Eiki
    Ohashi, Kadoaki
    Sugimoto, Seiichiro
    Hotta, Katsuyuki
    Tabata, Masahiro
    Toyooka, Shinichi
    Maeda, Yoshinobu
    Miyahara, Nobuaki
    INTERNAL MEDICINE, 2024,
12345